In Conversation

The leader of the commission for health in the Algerian parliament’s upper chamber speaks out about new legislation under review, identifies other shortcomings in the country’s healthcare system and…

The global CEO of Arianne, who herself happens to be American-Algerian, outlines why, in an era of clinical research globalisation, the country has all the right fundamentals…

“ LSK Global PS CEO Young-Jack Lee discusses the influence of global CROs on the quality of Korean research, and outlines his own strategy for competing in… ”
“ Sanofi’s Korean affiliate is the fifth largest recipient of clinical trial investments after the United States, France, Germany and the United Kingdom. ”
“ Song In-Keum, chairman of the Korean Medical Devices Industry Association (KMDIA), discusses current opportunities offered by Korea’s growing medtech industry. ”
“ The Korean Institute of Toxicology (KIT) is a government-funded research institute that evaluates the safety of medicine, bio-related products and chemicals. PharmaBoardroom talks to Lee Sang-Joon,… ”
“ Korea possesses enormous potential to become an exporter of futuristic health systems in the near future, and has already started the process. Kim Han-Joong, chairman of… ”
“ The Korea Drug Research Association (KDRA) was founded in 1986 to represent local pharmaceutical companies in their mission for global drug development. Kang-Choo Lee, president of… ”
“ The president of Astellas Korea offers his perspectives on Korea as a base for primary and clinical research, and the company's recent partnerships in the country. ”
“ The head researcher at P&K Skin Research Center discusses the potential of South Korea as a clinical trial hub, and the company's current expansion plans. ”
“ Don Hyun, president of MSD Korea, shares his vision to bring Korean pharmaceutical companies to the global stage and to bring a locally produced drug to… ”
“ The director of the Hanyang University Hospital for Rheumatic Diseases (HUHRD), discusses Korea’s leading role in developing biosimilars as well as the hospital’s efforts to curb… ”
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here